Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia.
作者:
主题词
成年人(Adult);抗肿瘤药(Antineoplastic Agents);亚洲(Asia);化学疗法, 辅助(Chemotherapy, Adjuvant);顺铂(Cisplatin);共病现象(Comorbidity);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);鼻咽肿瘤(Nasopharyngeal Neoplasms);患病率(Prevalence);辐射损伤(Radiation Injuries);辐射增敏药(Radiation-Sensitizing Agents);放射疗法, 适形(Radiotherapy, Conformal);危险因素(Risk Factors);存活率分析(Survival Analysis);存活率(Survival Rate);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1093/jrr/rrs115
PMID
23192700
发布时间
2021-10-21
- 浏览56
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文